Drugs give FTSE a lift

clock

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen 0.62% to 200.5p after HSBC rated it as "overweight" with a price target of 240p. Sainsbury has been started with an 'underweight' recommendation and has fallen 0.22% to 334.25p. In Japan, the Nikkei 225 Stock Average added 66.88 points, or 0.4%, to 15,638.5 points as a US manufacturing report fuelled speculation the Federal Reserve might refrain from raising interest rates. Sony ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

As good as... Should investors rely on gold to protect portfolios during market dips?

As good as... Should investors rely on gold to protect portfolios during market dips?

'Gold is often bought more on hope than expectation'

James Flintoft
clock 04 December 2025 • 3 min read
Darius McDermott: The uncertain future of the US dollar

Darius McDermott: The uncertain future of the US dollar

'Investors need to be aware of the potential vulnerability of the dollar'

Darius McDermott
clock 03 December 2025 • 5 min read
Watch Professional Adviser's Working Lunch with Baillie Gifford - Unlocking Opportunities Beyond the US: Why now for the Baillie Gifford Managed Fund

Watch Professional Adviser's Working Lunch with Baillie Gifford - Unlocking Opportunities Beyond the US: Why now for the Baillie Gifford Managed Fund

Catch up on the discussion

Professional Adviser
clock 01 December 2025 • 1 min read